Harnessing computational intelligence for synthetic lethality: A roadmap from network biology to interpretable deep

Yumi Noh1, Mohamed El-Agamy Farh2, Jae Yong Ryu3

  • 1Data Convergence Drug Research Center, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea; Department of Medicinal and Pharmaceutical Chemistry, University of Science and Technology, Daejeon 34129, Republic of Korea.

New Biotechnology
|June 9, 2026
PubMed

Insights

Synthetic lethality (SL) computational discovery faces challenges due to vast gene interactions. This review synthesizes methods and offers best practices for evaluating SL models, addressing drug resistance for precision oncology.

Area of Science:

  • Oncology
  • Computational Biology
  • Genetics

Background:

  • Synthetic lethality (SL) offers targeted cancer therapy by exploiting genetic vulnerabilities.
  • Experimental screening for SL is challenging due to the vast number of gene interactions.
  • Computational approaches are crucial for efficient SL discovery.

Purpose of the Study:

  • To provide a comparative synthesis of computational SL discovery architectures.
  • To establish evidence-based best practices for evaluating SL prediction models.
  • To discuss synthetic rescue and its role in drug resistance for clinical translation.

Main Methods:

  • Review and synthesis of computational SL discovery methods, including network-based models, graph transformers, and knowledge graph reasoning.
  • Analysis of methodological evaluation strategies: data splitting, metric selection, and negative sampling.
  • Integration of multi-omics data and interpretable deep learning for predicting SL candidates.

Main Results:

  • A comparative overview of diverse computational SL discovery architectures is presented.
  • Best practices for rigorous methodological evaluation are provided, addressing class imbalance and negative sampling.
  • A framework for prioritizing SL candidates robust to resistance mechanisms is proposed.

Conclusions:

  • Computational methods are essential for navigating the complexity of synthetic lethality discovery in precision oncology.
  • Standardized evaluation and consideration of resistance mechanisms are key for clinical translation of SL therapies.
  • This review offers a roadmap to bridge computational predictions with actionable clinical insights.

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Synthetic Biology02:55

Synthetic Biology

Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...